Literature DB >> 11385364

Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.

E N Atochina1, J M Beck, S T Scanlon, A M Preston, M F Beers.   

Abstract

Surfactant proteins SP-A and SP-D, members of the collectin family, have been shown to play a significant role in lung host defense. Both proteins selectively bind Pneumocystis carinii (PC) organisms and modulate the interaction of this pathogen with alveolar macrophages. We hypothesized that the expression and distribution of lung collectins SP-A and SP-D is altered by PC lung infection. PC organisms (2 x 10(5)) were inoculated intratracheally into C.B-17 scid/scid mice that do not require steroids for immunosuppression. Four weeks after inoculation, bronchoalveolar lavage (BAL) fluid was fractionated into three fractions-cell pellet, large aggregate (LA), and small aggregate (SA) surfactant-and each fraction was analyzed for the expression of surfactant components. In uninfected mice, the majority of SP-A (62% +/- 10%) was found in association with lipids in the LA fraction, while 55% +/- 14% of SP-D was distributed in the SA fraction. In contrast, both hydrophobic proteins SP-B and SP-C were associated exclusively with LA. PC infection resulted in major changes in the expression of all surfactant components. Total protein content of LA was unchanged by PC infection (115% +/- 18% of control), whereas SA protein content markedly increased (240% +/- 18% of control level, P <.001). In contrast, the phospholipid content of LA was significantly decreased (53% +/- 5% of control level, P <.001), whereas the SA phospholipid content of infected mice was increased (172% +/- 16% of control level, P <.001). By Western blotting, PC pneumonia (PCP) induced a 3-fold increase in the total alveolar SP-D protein that was reflected mainly in increases in SA SP-D (454% +/- 135% of control, P <.05). The total alveolar SP-A protein content was also increased in PCP because of a large increase in SP-A in SA (720% +/- 115% of control, P <.05); SP-A levels in LA were unchanged. The increases in lung collectin expression were selective, because PCP resulted in the down-regulation of both SP-B and SP-C in LA (5% +/- 2% and 13% +/- 2% of control, respectively, P <.001). We conclude that PCP induces marked elevations in alveolar collectin levels because of increased expression and accumulation of SP-A and SP-D protein in SA surfactant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385364     DOI: 10.1067/mlc.2001.115220

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  16 in total

1.  Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.

Authors:  Ingrid S Lundgren; Janet A Englund; Lauri M Burroughs; Troy R Torgerson; Suzanne Skoda-Smith
Journal:  Pediatr Infect Dis J       Date:  2012-01       Impact factor: 2.129

Review 2.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury.

Authors:  Maria Quisgaard Gaunsbaek; Karina Juhl Rasmussen; Michael F Beers; Elena N Atochina-Vasserman; Soren Hansen
Journal:  Lung       Date:  2013-02-24       Impact factor: 2.584

4.  Alveolar surfactant protein D content modulates bleomycin-induced lung injury.

Authors:  John Casey; Jennifer Kaplan; Elena N Atochina-Vasserman; Andrew J Gow; Helchem Kadire; Yaniv Tomer; James H Fisher; Samuel Hawgood; Rashmin C Savani; Michael F Beers
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

5.  Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis.

Authors:  Shin-Ichi Nureki; Yaniv Tomer; Alessandro Venosa; Jeremy Katzen; Scott J Russo; Sarita Jamil; Matthew Barrett; Vivian Nguyen; Meghan Kopp; Surafel Mulugeta; Michael F Beers
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

6.  Surfactant dysfunction and lung inflammation in the female mouse model of lymphangioleiomyomatosis.

Authors:  Elena N Atochina-Vasserman; Chang-Jiang Guo; Elena Abramova; Thea N Golden; Michael Sims; Melane L James; Michael F Beers; Andrew J Gow; Vera P Krymskaya
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 7.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

8.  Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.

Authors:  Elena N Atochina-Vasserman; Andrew J Gow; Helen Abramova; Chang-Jiang Guo; Yaniv Tomer; Angela M Preston; James M Beck; Michael F Beers
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Effects of decreased calmodulin protein on the survival mechanisms of alveolar macrophages during Pneumocystis pneumonia.

Authors:  Mark E Lasbury; Pamela J Durant; Chung-Ping Liao; Chao-Hung Lee
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

10.  Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages.

Authors:  Suk-Joong Yong; Zvezdana Vuk-Pavlovic; Joseph E Standing; Erika C Crouch; Andrew H Limper
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.